Very early researchStudy completedNCT02113657
What this trial is testing
T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer
Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 30